# Vaccine Therapy in Treating Patients With Breast Cancer

> **NCT00524277** · PHASE2 · COMPLETED · sponsor: **San Antonio Military Medical Center** · enrollment: 456 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** GP2 peptide + GM-CSF vaccine
- **BIOLOGICAL:** GM-CSF (sargramostim)
- **BIOLOGICAL:** AE37 + GM-CSF vaccine
- **BIOLOGICAL:** GM-CSF (sargramostim)

## Key facts

- **NCT ID:** NCT00524277
- **Lead sponsor:** San Antonio Military Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2014-12-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2020-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524277, "Vaccine Therapy in Treating Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00524277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*